BILLING NEWS

New Waived Tests

CR7694 announces the latest 11 tests approved by the FDA as waived tests under CLIA effective April 2, 2012. The CPT codes for the following new tests must have the modifier QW, defined as CLIA waived test, to be recognized as a waived test.

TESTS GRANTED WAIVED STATUS UNDER CLIA

CPT CodeEffective DateDescription
82274QW
G0328QW
September 8, 2004 Hemosure One-Step Fecal Occult Blood Test
81003QW October 28, 2009 Acon Mission U120 Urine Analyzer
G0434QW May 5, 2011 Premier Integrity Solutions P/Tox Drug Screen Cup {OTC}
81003QW June 2, 2011 BTNX Rapid Response U120 Urine Analyzer
G0434QW July 7, 2011 Instant Technologies, Inc. iCassette DX Drug Screen Test
G0434QW July 19, 2011 Express Diagnostic Int’l Inc DrugCheck Waive RT (Model 9308z)
80061QW, 82465QW, 82947QW, 82950QW, 82951QW, 82952QW, 83718QW, 84450QW, 84460QW,
84478QW
August 16, 2011 Alere Cholestech LDX {Whole Blood}
82055QW September 13, 2011 Acon Laboratories Inc. Mission Saliva Alcohol Test Strip
G0434QW September 13, 2011 Amedica Biotech Instant Test Cup
81003QW September 26, 2011 Immunostics Inc., Detector Uristrip+ Analyzer
82055QW October 4, 2011 Teco Diagnostics Saliva Alcohol Test
86386QW January 1, 2012 Alere NMP22 BladderChek Test (Prescription Home Use)
86386QW January 1, 2012 Alere NMP22 BladderChek Test (Professional Use)

For 2012, the new CPT code 86386 was developed for the Nuclear Matrix Protein 22 (NMP22), qualitative Therefore, the CPT code assigned to the Matritech, Inc. BladderCheck test. NMP22 Test for Professional and Prescription Home Use is changed to 86386QW with an effective date of January 1, 2012.


SOURCE: Source
INDUSTRY NEWS TAGS: CMS, Laboratory


SHARE THIS NEWS POST:

Billing News By TAG

Billing News By DATE